Mary Eapen
Mary Eapen
Not available.
Increased percentages of circulating T follicular helper cells associate with disease subtype and activity in pediatric immune cytopenias [0.03%]
外周血T滤泡辅助细胞比例与儿童免疫性细胞减少综合征的类型和活动度相关
Emily M Harris,Aleksandra Bourdine,Logan Magin et al.
Emily M Harris et al.
Immune thrombocytopenia (ITP), warm autoimmune hemolytic anemia (wAIHA), and Evans Syndrome (ES) have unpredictable disease activity and are sometimes associated with monogenetic disorders and/or extra-hematologic autoimmunity. ITP and immu...
Tiffany A Thomas,Steven L Spitalnik
Tiffany A Thomas
Not available.
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers [0.03%]
伊沙佐米在适合移植的多发性骨髓瘤患者中的维持治疗：德国三大中心的真实世界证据
Peter May,Michael Rassner,Marion Hoegner et al.
Peter May et al.
Not available.
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma [0.03%]
一名原发性中枢神经系统淋巴瘤患者在接受双重靶向CD20/CD19的ZAMTOCABTAGENE AUTOLEUCEL（tandem CAR-T）细胞治疗后获得完全缓解并实现中枢神经浸润案例报告
Nancy M Hardy,Jean A Yared,Tim Luetkens et al.
Nancy M Hardy et al.
Not available.
Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study [0.03%]
BCR-ABL1融合基因e13a3罕见变异的慢性髓性白血病患者对asciminib耐药的一例报道
Birte Kristin Jung,Sandra Weißmann,Caroline Schock et al.
Birte Kristin Jung et al.
Not available.
Sandeep K Prabhu
Sandeep K Prabhu
Not available.
A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns [0.03%]
初治慢性粒单细胞白血病治疗方案的回顾性分析：对生存期和反应模式的影响
Muhammad Yousuf,Priyansh Faldu,Maymona Abdelmagid et al.
Muhammad Yousuf et al.
In a retrospective analysis of 457 Mayo Clinic patients (median age 72 years) with chronic myelomonocytic leukemia (CMML; proliferative 38%; CMML-2 15%), overall survival (OS), calculated from time of diagnosis, was not differentially affec...
m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemia [0.03%]
急性髓系白血病中M6A和NuRD复合物调节单核细胞分化及BCL2/BCL2L1抑制剂抗性
Jackson Brim-Edwards,Karen Morris,Quinlan Morrow et al.
Jackson Brim-Edwards et al.
Frontline use of the BCL2 inhibitor, venetoclax, for acute myeloid leukemia (AML) has resulted in broad improvements in patient outcome. A major remaining challenge is the development of venetoclax resistance, frequently driven by compensat...
Platelets-driven monocyte activation promotes hypoxic thromboinflammation through the HIF-1α-NLRP3-EGR-1 axis [0.03%]
血小板驱动的单核细胞活化通过HIF-1α-NLRP3-EGR-1轴促进缺血性血栓炎症反应
Shankar Chanchal,Kashika Singh,Raishal Safdar et al.
Shankar Chanchal et al.
Hypoxia exacerbates thromboembolism and sterile inflammation through NLRP3 inflammasome, which is directly activated by HIF-1α that plays a pivotal role in potentiating deep vein thrombosis (DVT). One of the clinical manifestations of thro...